What is she best known for?
The fields of study she is best known for:
Her primary areas of investigation include Veterinary medicine, Rhipicephalus sanguineus, Leishmania infantum, Tick and Zoology.
Her study in Veterinary medicine is interdisciplinary in nature, drawing from both Parasitology, CATS, Aelurostrongylus abstrusus and Dirofilaria repens, Dirofilaria immitis.
Her research integrates issues of Rhipicephalus, Tick-borne disease, Tick infestation and Canis in her study of Rhipicephalus sanguineus.
Her work carried out in the field of Leishmania infantum brings together such families of science as Serology, Seroprevalence and Group B.
Her work in Tick covers topics such as Sensu which are related to areas like Taxonomy, Paraphyly, Genetic diversity, Sister group and Entomology.
Her work on Cercopithifilaria, Cercopithifilaria bainae, Genus and Acanthocheilonema reconditum as part of general Zoology research is often related to Northern italy, thus linking different fields of science.
Her most cited work include:
- On a Cercopithifilaria sp. transmitted by Rhipicephalus sanguineus: a neglected, but widespread filarioid of dogs (335 citations)
- Morphological and genetic diversity of Rhipicephalus sanguineus sensu lato from the New and Old Worlds (175 citations)
- Ticks infesting humans in Italy and associated pathogens (95 citations)
What are the main themes of her work throughout her whole career to date?
Maria Stefania Latrofa spends much of her time researching Veterinary medicine, Zoology, Rhipicephalus sanguineus, Tick and Leishmania infantum.
Her biological study focuses on Tick infestation.
Her Zoology research includes elements of Nematode, Feces, Zoonosis and Phylogenetic tree.
Her Rhipicephalus sanguineus study integrates concerns from other disciplines, such as Sensu, Rhipicephalus and Filarioidea.
Her Tick research is multidisciplinary, relying on both Nymph and Babesia canis.
Her studies deal with areas such as Parasite load, Flumethrin and Serology as well as Leishmania infantum.
She most often published in these fields:
- Veterinary medicine (46.67%)
- Zoology (24.17%)
- Rhipicephalus sanguineus (24.17%)
What were the highlights of her more recent work (between 2019-2021)?
- Zoology (24.17%)
- Veterinary medicine (46.67%)
- Virology (15.00%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Zoology, Veterinary medicine, Virology, Dirofilaria immitis and Dirofilaria repens.
The study incorporates disciplines such as Feces, 16S ribosomal RNA, Spotted fever and Phylogenetic tree in addition to Zoology.
Her Veterinary medicine research includes themes of Phlebotomus, Leishmania species, Cutaneous leishmaniasis, Leishmania and Common species.
Her biological study spans a wide range of topics, including TaqMan and Duplex.
Maria Stefania Latrofa focuses mostly in the field of Dirofilaria immitis, narrowing it down to matters related to Onchocercidae and, in some cases, Culicoides, Microfilaria, Acaricide, Haplotype and Tick infestation.
Her Canis research focuses on subjects like Anaplasma platys, which are linked to Rhipicephalus sanguineus.
Between 2019 and 2021, her most popular works were:
- Hyperendemic Dirofilaria immitis infection in a sheltered dog population: an expanding threat in the Mediterranean region. (10 citations)
- Canine vector-borne pathogens from dogs and ticks from Tamil Nadu, India. (7 citations)
- A molecular survey of vector-borne pathogens and haemoplasmas in owned cats across Italy. (4 citations)
In her most recent research, the most cited papers focused on:
Maria Stefania Latrofa mainly focuses on Veterinary medicine, Vector, High prevalence, Dirofilaria repens and Culex pipiens.
Her work deals with themes such as Ehrlichia canis and Canis, which intersect with Veterinary medicine.
Maria Stefania Latrofa has included themes like Mediterranean climate and Dirofilaria immitis in her Vector study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
